Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
13.52 USD | -6.40% | +9.78% | 0.00% |
May. 14 | Kyverna Therapeutics Q1 Loss Narrows | MT |
May. 14 | Kyverna Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
0.00% | 623M | |
+57.92% | 59.34B | |
+43.17% | 40.24B | |
-4.96% | 39.88B | |
-5.56% | 28.55B | |
+15.22% | 27.26B | |
-21.05% | 19.23B | |
+32.85% | 12.61B | |
+2.48% | 12.49B | |
+25.83% | 12.28B |
- Stock Market
- Equities
- KYTX Stock
- News Kyverna Therapeutics, Inc.
- Morgan Stanley Starts Kyverna Therapeutics With Overweight Rating